Document ID: chunk:federal_register_of_legislation:F2024L00217:reg:7
Version: federal_register_of_legislation:F2024L00217
Segment Type: reg
Provision Reference: reg 7
Character Range: 1704–3512

7               Kind of injury, disease or death to which this Statement of Principles relates
(1)          This Statement of Principles is about acute myeloid leukaemia and death from acute myeloid leukaemia.
Meaning of acute myeloid leukaemia
(2)          For the purposes of this Statement of Principles, acute myeloid leukaemia:
(a)          means a malignant neoplasm of the blood characterised by clonal proliferation of morphologically immature cells committed to the myeloid cell lineage, with an excess of myeloblasts in bone marrow, peripheral blood or other tissues; and
(b)          includes:
(i)            acute myeloid leukaemia with defining genetic abnormalities (for example, acute myeloid leukaemia with NPM1 mutation);
(ii)         acute myeloid leukaemia, myelodysplasia-related genetic abnormalities;
(iii)       acute myeloid leukaemia with minimal differentiation, or without maturation or with maturation;
(iv)        acute myeloblastic leukaemia;
(v)          acute promyelocytic leukaemia;
(vi)        acute myelomonocytic leukaemia;
(vii)     acute monoblastic/monocytic leukaemia;
(viii)   acute erythroid leukaemia;
(ix)        acute megakaryoblastic leukaemia;
(x)          acute basophilic leukaemia;
(xi)        acute panmyelosis with myelofibrosis;
(xii)     myeloid sarcoma;
(xiii)   acute myeloid leukaemia, not otherwise specified; and
(c)          excludes:
(i)            chronic myeloid leukaemia; and
(ii)         myelodysplastic syndrome.
Death from acute myeloid leukaemia
(3)          For the purposes of this Statement of Principles, acute myeloid leukaemia, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's acute myeloid leukaemia.
Note: terminal event is defined in the Schedule 1 – Dictionary.